ES2575234B1 - Non-invasive insulin delivery team - Google Patents
Non-invasive insulin delivery team Download PDFInfo
- Publication number
- ES2575234B1 ES2575234B1 ES201531400A ES201531400A ES2575234B1 ES 2575234 B1 ES2575234 B1 ES 2575234B1 ES 201531400 A ES201531400 A ES 201531400A ES 201531400 A ES201531400 A ES 201531400A ES 2575234 B1 ES2575234 B1 ES 2575234B1
- Authority
- ES
- Spain
- Prior art keywords
- invasive
- insulin
- equipment
- insulin delivery
- apply
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 10
- 102000004877 Insulin Human genes 0.000 title abstract 5
- 108090001061 Insulin Proteins 0.000 title abstract 5
- 229940125396 insulin Drugs 0.000 title abstract 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000002641 glycemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/6815—Ear
- A61B5/6817—Ear canal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Otolaryngology (AREA)
- Radiology & Medical Imaging (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Equipo de suministro de insulina no invasivo#El equipo de la invención permite medir y calcular en tiempo real de forma no invasiva un perfil glucémico real a partir del cual aplicar igualmente de forma no invasiva, aportaciones de insulina, debidamente dosificadas y en los momentos concretos en los que la misma es necesaria, lo que redunda en una mejora sustancial en la calidad de vida para el diabético, no sufriendo ningún tipo de proceso invasivo.#Para ello, el equipo está constituido a partir de un sensor del nivel de glucemia (1) con un espectrofotómetro (5), una muñequera (2) con un display (16) para visualización de dichos niveles, y un cinturón (3) asociado a una bomba de insulina no invasiva (20), basada en la iontoforesis, que aplica la insulina por medio de dos electrodos (21) y (22) de forma automática e indolora.Non-invasive insulin delivery equipment # The equipment of the invention allows to measure and calculate in real time in a non-invasive way a real glycemic profile from which to also apply non-invasively, insulin inputs, duly dosed and at specific times in which it is necessary, which results in a substantial improvement in the quality of life for the diabetic, not undergoing any type of invasive process. # To do this, the equipment is constituted from a blood glucose level sensor ( 1) with a spectrophotometer (5), a wristband (2) with a display (16) for displaying these levels, and a belt (3) associated with a non-invasive insulin pump (20), based on iontophoresis, which apply insulin by means of two electrodes (21) and (22) automatically and painlessly.
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531400A ES2575234B1 (en) | 2015-09-30 | 2015-09-30 | Non-invasive insulin delivery team |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201531400A ES2575234B1 (en) | 2015-09-30 | 2015-09-30 | Non-invasive insulin delivery team |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2575234A1 ES2575234A1 (en) | 2016-06-27 |
| ES2575234B1 true ES2575234B1 (en) | 2017-04-05 |
Family
ID=56134735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201531400A Expired - Fee Related ES2575234B1 (en) | 2015-09-30 | 2015-09-30 | Non-invasive insulin delivery team |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2575234B1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5115133A (en) * | 1990-04-19 | 1992-05-19 | Inomet, Inc. | Testing of body fluid constituents through measuring light reflected from tympanic membrane |
| WO2000047109A1 (en) * | 1999-02-12 | 2000-08-17 | Cygnus, Inc. | Devices and methods for frequent measurement of an analyte present in a biological system |
-
2015
- 2015-09-30 ES ES201531400A patent/ES2575234B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2575234A1 (en) | 2016-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2017005539A (en) | PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY | |
| MA54623A (en) | GLUCOSE-RESPONSIVE INSULIN DELIVERY SYSTEM USING HYPOXIA-SENSITIVE NANOCOMPOSITES | |
| EP3933845A3 (en) | Subcutaneous outpatient management | |
| EA201491934A1 (en) | GLUCAGON-LIKE PEPTIDE-2 ANALOGES (GLP-2) | |
| ES2721635T3 (en) | Biomarker imaging for the diagnosis of back pain | |
| CO7131366A2 (en) | Treatment of circadian rhythm disorders | |
| EA201590058A1 (en) | ANALOGUE GLUACAGONA | |
| EP4233723A3 (en) | Lancet device with first-drop removal | |
| WO2016005586A3 (en) | Titration of basal insulin with two modes | |
| CY1119850T1 (en) | USE OF METFORMIN IN COMBINATION WITH AN INTERACTIVE GLYKINASE AND COMPOSITIONS INCLUDING METFORMIN AND ACTIVATOR | |
| PE20161145A1 (en) | METHODS AND TOOLS RELATED TO CONTRAST MEDIA ADMINISTRATION | |
| EA201700123A1 (en) | METHOD FOR PREDICTING A VARIANT OF A MEDICAL PREPARATION FOR THE TREATMENT OF DEPRESSION | |
| MX2017009294A (en) | Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide. | |
| CR20140473A (en) | PIRAZOL COMPOUNDS AS SGLT1 INHIBITORS | |
| EA201792030A1 (en) | TREATMENT OF PATIENTS WITH DIABETES MELLITUS TYPE 2 | |
| EA201591123A1 (en) | THE COMBINATION OF THE AGONIST GLP1R AND METHFORMIN AND WAYS OF THEIR APPLICATION IN THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS | |
| ES2575234B1 (en) | Non-invasive insulin delivery team | |
| FI20130323A7 (en) | A method for measuring the threshold value of exercise that promotes fat and cholesterol metabolism and reduces the amount of adipose tissue in people who are overweight or at increased risk of heart disease and diabetes | |
| CL2018001782A1 (en) | Methods and compositions for the treatment of hunter syndrome. | |
| RU2012144141A (en) | METHOD FOR EVALUATING THE PROBABILITY OF OCCURRENCE OF FRACTURES IN OSTEOPOROSIS IN WOMEN | |
| Lamonaca et al. | PW170 Clinical Validation Of The Smartphone | |
| CY1124859T1 (en) | HOMODIMER PEPTIDE FOR THE TREATMENT OF DIABETES AND RELATED DISEASES | |
| Chadha | Interesting Case Conference | |
| Saenko et al. | Indices of cerebrovascular reactivity in patients with diabetes mellitus complicated with cardiovascular autonomic neuropathy | |
| del Águila-Carrasco et al. | OCT technique for evaluating diurnal variation in corneal thickness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2575234 Country of ref document: ES Kind code of ref document: B1 Effective date: 20170405 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20211004 |